The properties of a new synthetic LDL binding material, consisting of fragments of loosely crosslinked hydrogel. based on sulfated polyvinylalcohol are described. When incubated with 20 times its volume of plasma, this material binds up to 95% of the LDL, even from plasma with severely elevated LDL cholesterol levels (up to 20 mM). In addition a cholesterol-rich subfraction of VLDL is bound but HDL is not bound. After about 10 min binder/plasma contact the LDL removal is complete and no other additives are required. LDL binding capacity is dependent on the average binder particle size. indicating a restricted penetration of LDL particles into the binder matrix.
Introduction
2-fold normal, homozygotes up to IO-fold normal). These increased plasma LDL levels are caused by a lack of specific cell surface LDL receptors. Elevated LDL levels present an increased risk of the occurrence of atherosclerosis. Homozygote patients often die from a myocardial infarction before age 20. Atherosclerotic disease affects 40% of heterozygote males and 20% of heterozygote females before the age of 40, being fatal for almost a quarter of the males before they reach age 50 [l] .
A number of dietary and medical treatments reduce plasma LDL levels in FH patients to acceptable levels. especially when given in combination [2] . However, some medicines are not effec-.
. In the present paper we report on the preparation and properties of a new LDL binding material, based on sulfated polyvinylalcohol.
This material may offer a suitable and more economic alternative for the above-mentioned sepharose-based LDL sorbents.
Materials and Methods

Polyvinylalcohol
(PVA) (MW 14000-86000, obtained from Janssen Chimica, Beerse, Belgium) was sulfated by reaction with a pyridineS0, complex in excess pyridine (obtained from Merck, Darmstadt, F.R.G.) (molar ratio pyridine-SO,/PVA = 1.3/l), for 90 min at 105OC (molar ratio pyridine/PVA = l/l). The pyridine-SO, complex was prepared by adding chlorosulfonic acid (obtained from Merck, Darmstadt, F.R.G.) dropwise to cooled pyridine (1 mole chlorosulfonic acid/2 moles pyridine). After the sulfation reaction the reaction mixture was diluted in distilled water and neutralized with NaOH; the pyridine was distilled off under vacuum and the sulfated PVA (PVAS) was purified by dialysis against distilled water.
A dry product was obtained either by ethanol precipitation or by freeze-drying the dialyzed PVAS solution.
A loosely cross-linked hydrogel was obtained by y-irradiation of aqueous solutions of PVAS in glass tubes of 8 mm diameter. Irradiation dose was varied between 25 and 100 kGy (60Co, dose rate 3.5 kGy/h), PVAS concentrations between 10 and 60% (w/w). After irradiation the hydrogels were pushed from the tubes and thoroughly washed with distilled water. After this washing step (accompanied by extensive swelling; see Results) the PVAS hydrogel was fragmented by one of the two following procedures:
( 1) 
Results
Sulfution
Depending on the molar ratio pyridine-SO, complex/PVA hydroxyl groups the substitution of the PVA hydroxyl groups by sulfate groups is 60-95s.
The experiments described were carried out with 80% sulfated PVA.
Hydrogel formation
After y-irradiation the binder contains 40-85s water. During the washing and equilibration in PBS the binder swells, due to osmotic pressure effects, to a water content of 95-99%. Table 1 shows the influence of both irradiation dose and PVAS concentration during radiation on the water content after equilibration in PBS. At higher water contents the hydrogels are more loosely cross-linked, improving the penetration of LDL particles into the binder matrix. A relatively low water content on the other hand indicates a high cross-linking density and therefore the possibility of a too finely meshed network inhibiting LDL penetration.
Lipoprotein binding to PVAS-hydrogelparticles
Upon incubation of PVAS-particles with 20 times its volume of plasma (from a pool composed of plasma of 5 male, normolipidemic volunteers aged 25-37, not suffering from any metabolic endocrine or infectious disease), the particles removed about 60% of the total amount of cholesterol within 10 min (Fig.  1 ). This is equivalent to the total amount of cholesterol in the LDL fraction in that plasma. Table 2 shows lipoprotein profiles before and after incubation of 1 volume binder particles with 20 volumes of titrated normal or hyperlipoproteinemic plasma. From these results it can be concluded that: (1) LDL is bound by 56-95%; (2) in case of HLP type IIa or b virtually all the LDL is bound; (3) VLDL is not, or for a much smaller percentage, bound in comparison to LDL. However, the percent cholesterol bound is always higher than the percent triglycerides bound from this fraction, indicating preferential binding of a cholesterol-rich subfraction of VLDL; (4) an extremely elevated VLDL concentration might reduce the LDL binding capacity (type IV plasma); (5) HDLz and HDL, are not bound. In addition, the gel was found to bind Lp(a) antigen from whole serum containing a high level of this antigen with a similar efficiency as apo B (Table 3) . Figure 2 shows the results of an experiment in which the LDL binder was incubated in varying binder/plasma ratios with 3 different plasmas with different total cholesterol levels and lipoprotein spectra. The LDL binder has a very high capacity for LDL binding; even when the binder is incubated with lo-20 times its own volume of plasma containing an extremely elevated choles- terol level (20.7 mM) 70-80% of the total amount of cholesterol is removed, equivalent to 80-95% of LDL cholesterol ( Fig. 2A) . The absolute amount of bound cholesterol increases with increasing total plasma cholesterol concentration and with increasing amounts of plasma a maximum is reached at a plasma/binder ratio of 20/l-40/1 (by volume). At higher ratios the absolute binding decreases (Fig. 2B) .
As shown in Table 1 a higher concentration  of  PVAS during irradiation results in a more densely cross-linked network. In order to study the effect of the mesh size of the gel on the LDL binding we prepared a series of hydrogels with increasing concentrations PVAS during y-irradiation (thus increasing cross-linking density). The results are summarized in Fig. 3 . In this figure we can distinguish 3 different regions: (1) below 30% PVAS no hydrogel is formed, (2) the gel network mesh size, (3) at PVAS concentrations higher than 40% the mesh size of the gel becomes limiting for effective LDL penetration, thus leading to a reduced cholesterol binding. In order to study the effect of the gel particle size on the cholesterol binding, gel particles were prepared by milling and sieving a freeze-dried hydrogel. As shown in Fig. 4 the cholesterol binding increases with decreasing gel particle size (thus increasing gel surface). With each sieve-fraction, except the coarsest, the amount of LDL cholesterol bound reached a maximum upon addition of increasing amounts of plasma and decreased again At a titrated plasma/ binder ratio of 20/l, 13% of the total calcium and 22% of the total magnesium was bound. At plasma/ binder ratios of 40/l and higher, divalent cation binding dropped to undetectable values. The binding of AT-III appeared to be strongly dependent on the plasma/binder ratio. Up to a plasma/binder ratio of 2, virtually all the AT-III is bound. An increase of this ratio results in a rapid reduction of the AT-III binding, so that at plasma/binder ratios over 20/l, less than 10% of the AT-III is bound by the PVAS hydrogel (Fig.  5) . Albumin and CX,-, q-, p-and y-globulins were not appreciably bound to the gel fragments in incubations with plasma/binder ratios of 20/l or higher (not shown).
Fibrinogen, however, was largely removed from titrated plasma in such incubations, which could be ascribed to extensive Fb degradation (Table 4 ).
Discussion
Loosely cross-linked, highly sulfated PVA hydrogels are able to bind LDL selectively and with high capacity from blood plasma. The LDL binding is reduced by very high VLDL levels (type IV HLP) and at very high plasma/binder ratios by other plasma factors *.
The LDL binding also depends on the mesh size of the network (a too finely meshed network inhibits LDL penetration into the gelmatrix) and on the particle size of the binder i.e. the total binder surface. The effects of both gel surface and degree of cross-linking on LDL binding indicate a restricted penetration of the LDL particle into the gelmatrix. Theoretical calculations for LDL penetration into the gelmatrix predict a penetration depth of LDL in the matrix of 10 pm. This means that only part of the total gel volume of the particles used is actually involved in the LDL Compared to other LDL binders, such as immobilized heparin or dextran sulfate, this binder has a very high capacity for LDL binding.
As shown in Fig. 2 the binder removes almost all the LDL from 10 to 20 times its own volume of plasma, even when plasma with extremely elevated LDL levels is used. Therefore, LDL plasma levels in FH patients could theoretically be lowered by 90% with only 150-300 ml binder particles. In a clinical situation, however, the LDL reduction will be less pronounced due to the limitations in extracorporeal blood volume (about 500 ml) and also due to the dilution of untreated with treated blood, resulting in a logarithmic decrease of the LDL level.
In contrast to immobilized heparin and dextran sulfate, no additives such as divalent cations are required for LDL removal by cross-linked PVAS particles, which not only simplifies clinical procedures, but also permits the use of citrate-based anticoagulants.
The results of these experiments suggest that an extracorporeal plasma treatment with sulfated polyvinylalcohol gels could offer a new and useful technique for lowering LDL levels of FH patients. Further research will be focussed on the biocompatibility of this new LDL binding material, as well as on the manner in which it can be incorporated in a device for extracorporeal LDL apheresis.
